Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 751–800 of 33810
each of Jack L. Wyszomierski, Heather L. Franklin, Natasha Hernday, Owen Hughes, Barbara Kosacz, Joseph M. Limber and Matthew Perry, voluntarily resigned as directors of the Company
each of Jack L. Wyszomierski, Heather L. Franklin, Natasha Hernday, Owen Hughes, Barbara Kosacz, Joseph M. Limber and Matthew Perry, voluntarily resigned as directors of the Company
On July 8, 2026, Stephen Mackintosh notified Sui Group Holdings Limited (the “Company”) of his resignation from his position as Chief Investment Officer of the Company, effective July 8, 2026.
On July 12, 2026, Paul J. Hennessy notified the Board of Directors (the “Board”) of Shutterstock, Inc. (the “Company”) of his decision to step down as the Company’s Chief Executive Officer and as a member of the Board, effective immediately.
on July 13, 2026, Robert M. Ginnan and the Company agreed that Mr. Ginnan will no longer serve as the Company’s Chief Financial Officer, effective July 13, 2026.
On July 9, 2026, Edward M. Weil, Jr., a Class III director and Chairman of the Board of Directors (the “ Board ”) of American Strategic Investment Co. (the “ Company ”), notified the Company of his resignation as a director on the Board, effective immediately.
Departure of Chief Executive Officer Kent P. Hawryluk will be stepping away from his role as the Company’s Chief Executive Officer and end his services as a member of the Board effective as of July 13, 2026.
On July 13, 2026, Lawson Whiting announced his decision to retire as President and Chief Executive Officer of Brown-Forman Corporation (the “Company”) after nearly 30 years of distinguished service to the Company, effective upon the appointment of his successor.
On July 7, 2026, Douglas Beck, the Principal Accounting Officer and Senior Vice President of Finance, Controller of SHF Holdings, Inc. (the “Company”), informed the Company of his decision to resign from his roles at the Company effective July 31, 2026.
On July 13, 2026, Tarsus Pharmaceuticals, Inc. (the “Company”) announced that Aziz Mottiwala would be leaving his role as the Company’s Chief Commercial Officer and leaving his employment with the Company on July 15, 2026, to pursue a new opportunity as Chief Executive Officer of a public medical device company.
On July 8, 2026, Ceva, Inc. (the “Company”) and Michael Boukaya, Executive Vice President and Chief Operating Officer of the Company, mutually agreed that Mr. Boukaya would resign from his position with the Company.
On July 10, 2026, the Board of Directors (the “Board”) of Fermi Inc. (the “Company”) received a letter from Mr. Miles Everson, a director designee of Toby Neugebauer, pursuant to which Mr. Everson resigned as a director of the Company, effective immediately (the “Resignation Letter”).
On July 7, 2026, Andrew J. Ritter resigned from the Board of Directors of Nordicus Partners Corporation (the “Company”), effective immediately, to pursue other time-consuming business opportunities.
Effective upon the consummation of the Merger, in accordance with the Merger Agreement, each of J. Martin Carroll, Sheldon L. Koenig, Robert E. Hoffman, Craig Thompson, Jay P. Shepard and Seth H.Z. Fischer, who constituted the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company, and Justin Bateman and Ankit Pareek, the directors of MergerCo immediately prior to the Effective Time, were elected as directors of the Company.
Effective upon the consummation of the Merger, in accordance with the Merger Agreement, each of J. Martin Carroll, Sheldon L. Koenig, Robert E. Hoffman, Craig Thompson, Jay P. Shepard and Seth H.Z. Fischer, who constituted the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company, and Justin Bateman and Ankit Pareek, the directors of MergerCo immediately prior to the Effective Time, were elected as directors of the Company.
Effective upon the consummation of the Merger, in accordance with the Merger Agreement, each of J. Martin Carroll, Sheldon L. Koenig, Robert E. Hoffman, Craig Thompson, Jay P. Shepard and Seth H.Z. Fischer, who constituted the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company, and Justin Bateman and Ankit Pareek, the directors of MergerCo immediately prior to the Effective Time, were elected as directors of the Company.
Effective upon the consummation of the Merger, in accordance with the Merger Agreement, each of J. Martin Carroll, Sheldon L. Koenig, Robert E. Hoffman, Craig Thompson, Jay P. Shepard and Seth H.Z. Fischer, who constituted the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company, and Justin Bateman and Ankit Pareek, the directors of MergerCo immediately prior to the Effective Time, were elected as directors of the Company.
Effective upon the consummation of the Merger, in accordance with the Merger Agreement, each of J. Martin Carroll, Sheldon L. Koenig, Robert E. Hoffman, Craig Thompson, Jay P. Shepard and Seth H.Z. Fischer, who constituted the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company, and Justin Bateman and Ankit Pareek, the directors of MergerCo immediately prior to the Effective Time, were elected as directors of the Company.
Effective upon the consummation of the Merger, in accordance with the Merger Agreement, each of J. Martin Carroll, Sheldon L. Koenig, Robert E. Hoffman, Craig Thompson, Jay P. Shepard and Seth H.Z. Fischer, who constituted the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company, and Justin Bateman and Ankit Pareek, the directors of MergerCo immediately prior to the Effective Time, were elected as directors of the Company.
With deep sadness, SouthState Bank Corporation (the “Company”), announced that James W. Roquemore, a member of the Company’s Board of Directors, passed away on July 9, 2026, after a long illness.
On July 8, 2026, Robert Jackson, Director of Kinetic Seas Incorporated, notified the Board of Directors of his resignation from all positions with the Company, effective the same day.
Dr. John R. Anderson notified Concentra Group Holdings Parent, Inc. (the “Company”) of his retirement from his position as Executive Vice President and Chief Medical Officer of the Company effective as of December 31, 2026.
John Bissell, Kathy Fish, John Hickox, Craig Rogerson, and Jim Stephanou informed the Company on July 9, 2026 that they will step down from the Board of the Company, effective July 31, 2026.
John Bissell, Kathy Fish, John Hickox, Craig Rogerson, and Jim Stephanou informed the Company on July 9, 2026 that they will step down from the Board of the Company, effective July 31, 2026.
John Bissell, Kathy Fish, John Hickox, Craig Rogerson, and Jim Stephanou informed the Company on July 9, 2026 that they will step down from the Board of the Company, effective July 31, 2026.
John Bissell, Kathy Fish, John Hickox, Craig Rogerson, and Jim Stephanou informed the Company on July 9, 2026 that they will step down from the Board of the Company, effective July 31, 2026.
John Bissell, Kathy Fish, John Hickox, Craig Rogerson, and Jim Stephanou informed the Company on July 9, 2026 that they will step down from the Board of the Company, effective July 31, 2026.
On July 10, 2026, each of William M. Goodyear and Mark McGowan submitted their resignations as directors of Enova International, Inc. (the “Company”), effective immediately.
On July 10, 2026, each of William M. Goodyear and Mark McGowan submitted their resignations as directors of Enova International, Inc. (the “Company”), effective immediately.
On July 7, 2026, James J. Ferguson III, Chief Medical Officer of Cadrenal Therapeutics, Inc. (the “Company”), advised the Board of Directors of the Company of his decision to resign from his position as Chief Medical Officer of the Company, effective July 31, 2026 (the “Separation Date”).
On July 6, 2026, George Holding notified Trump Media & Technology Group Corp. (the “Company”) of his resignation from its Board of Directors (the “Board”), and the committees on which he served, effective immediately.
Harriette Lo resigned from her role as the Registrant’s Co-Chairwoman, director
Yee Wei Tan resigned from his role as the Registrant’s director and Chief Financial Officer.
Han Wei Wang resigned from his role as the Registrant’s director and Chief Executive Officer.
On July 1, 2026, AppTech Payments Corp. (the “Company”) released Thomas J. DeRosa from his roles as President and Chief Executive Officer of the Company, effective immediately.
On July 7, 2026, Park Aerospace Corp. terminated the employment of Cory Nickel, Senior Vice President and General Manager of the Company, effective immediately.
On July 8, 2026, Nathaniel Fick resigned from his role as a Class III director of the Board, effective July 8, 2026, to accept an appointment as preferred stock director of the Board.
On July 8, 2026, Greg Nixon resigned from his role as a preferred stock director of the Board of Directors (the “Board”) of Eos Energy Enterprises, Inc. (the “Company”), effective July 8, 2026, to devote more time to other business ventures.
On July 2, 2026, Austin Kaplicer, Chief Accounting Officer and principal accounting officer of Angi Inc. (the “Company”), notified the Company of his decision to resign, effective as of August 6, 2026.
Effective July 9, 2026, the employment of Mr. Kirk D. Jensen with the registrant and its wholly owned subsidiary First Interstate Bank as Executive Vice President and General Counsel/Corporate Secretary was terminated involuntarily and without cause
On July 8, 2026, Paul Grewal notified Coinbase Global, Inc. (“Coinbase” or the “Company”) of his intention to step down as Chief Legal Officer and Secretary of Coinbase, effective July 31, 2026.
On July 7, 2026, Daniel R. Kozlowski notified the Board of Directors (the “ Board ”) of the Registrant of his resignation from the Board, effective immediately.
On July 2, 2026, Matt Link notified FibroBiologics, Inc. (the “Company”) that he was resigning from the Board of Directors (the “Board”), effective as of July 2, 2026.
On July 2, 2026, Mike Schmidt notified Nixxy, Inc. (the "Company") of his decision to resign as Chief Executive Officer of the Company and as a member of the Company's Board of Directors (the "Board"), effective immediately.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.